Jason Patrick Meyenburg

Insider Reports History

Entity
Individual
Location
C/O Sucampo Pharmaceuticals, 805 King Farm Boulevard, Suite 550, Rockville, MD
Signature
/s/ Brian Piekos, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Patrick Meyenburg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Gemini Therapeutics, Inc. /DE Chief Executive Officer, Director Common Stock 13K $879K $67.65 May 14, 2021 Direct
Gemini Therapeutics, Inc. /DE Chief Executive Officer, Director Restricted Stock Units 124K Jan 3, 2022 Direct

Insider Reports Filed by Jason Patrick Meyenburg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IRON Gemini Therapeutics, Inc. /DE Jan 3, 2022 1 $0 4 Jan 5, 2022 Chief Executive Officer, Director
IRON Gemini Therapeutics, Inc. /DE May 14, 2021 1 $123K 4 May 18, 2021 President & CEO, Director